Prognostic staging for therapy of rheumatoid arthritis

Seminars in Arthritis and Rheumatism

Volumn 21, Issue 2 SUPPL. 1, 1991, Pages 40-43

  Willkens, Robert F ^a  

^a NONE

Author keywords

prognostic staging; Rheumatoid arthritis; therapy

Indexed keywords

AZATHIOPRINE; CORTICOSTEROID; CYCLOPHOSPHAMIDE; GOLD; HYDROXYCHLOROQUINE; METHOTREXATE; NONSTEROID ANTIINFLAMMATORY AGENT; PENICILLAMINE; SALAZOSULFAPYRIDINE;

CLASSIFICATION; DISEASE ACTIVITY; DRUG INDICATION; HUMAN; PRIORITY JOURNAL; PROGNOSIS; REVIEW; RHEUMATOID ARTHRITIS;

ARTHRITIS, RHEUMATOID; HUMAN; IMMUNOGENETICS; PROGNOSIS;

EID: 0025988353     PISSN: 00490172     EISSN: None     Source Type: Journal    
DOI: 10.1016/0049-0172(91)90050-A     Document Type: Article

References (31)

1. Longterm outcome of treating rheumatoid arthritis: Results after 20 years
2. Rheumatoid arthritis: Disappointing long-term outcomes despite successful short-term clinical trials
3. Natural history and treatment decisions in rheumatoid arthritis revisited
4. Does drug therapy slow radiographic deterioration in rheumatoid arthritis?
5. Remodeling the pyramid: A concept whose time has come
6. New perspectives of secondary and tertiary therapy for rheumatoid arthritis
7. Clinical reasoning in the management of rheumatoid arthritis
8. Clinical and laboratory assessment of outcome in rheumatoid arthritis
9. Prospective study of early rheumatoid arthritis I. Prognostic value of IgA rheumatoid factor
10. Circulating immune complexes and rheumatoid arthritis
11. Observations on the eosinophilia of certain patients with rheumatoid arthritis
12. Biochemical and clinical changes in rheumatoid arthritis. Their relation to the action of anti-rheumatoid drugs
13. Rheumatoid arthritis: Relation of serum c-reactive protein and erythrocyte sedimentation rates to radiographic changes
14. Studies of isolated synovial lining cells of rheumatoid and non rheumatoid synovial membranes
15. Immune function in severe, active rheumatoid arthritis. A relationship between peripheral blood mononuclear cell proliferation to soluble antigens and synovial tissue immunohistologic characteristics
16. The genetics of rheumatoid disease in man
17. Identification of HLA-Dw 15 genes in DR4+ rheumatoid arthritis
18. HLA genes associated with rheumatoid arthritis: Identification of susceptibility alleles using specific oligonucleotide probes
19. Association of HLA-Dw16 with rheumatoid arthritis in Yakima Indians
20. Drug therapy in rheumatoid arthritis
21. A toxicity for comparison of side effects among different drugs
22. Lack of correlation between the Steinbrocker staging of hand radiographs and the functional health status of individuals with rheumatoid arthritis
23. Which traditional measures should be used in rheumatoid arthritis clinical trials?
24. Does aggressive therapy of rheumatoid arthritis affect outcome?
25. The cooperative efficacy and toxicity of second-line drugs in rheumatoid arthritis
26. Aspirin, hydroxychloroquine, and hepatic enzyme abnormalities with methotrexate in rheumatoid arthritis
27. Rheumatoid arthritis, Pathophysiology and implications for therapy
28. Corticosteroids in rheumatoid arthritis
29. Corticosteroids inhibit prostaglandin release from perfused and mesenteric blood vessels of rabbit and from perfused lungs of sensitized guinea pig
30. Leukotrienes: Mediators of immediate hypersensitivity reactions and inflammation